Topical mesalazine sustained-release tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Topical mesalazine sustained-release tablets, covering 2023-02-01 to 2023-02-01. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer [Phase 3]